Home » EPIC Archives: REDX

REDX News Archives



Redx Pharma Phase I trial resumed

Hardman & Co

Redx Pharma plc (LON: REDX) is a clinical-stage R&D company focused on drugs targeting oncology and fibrotic disease. 2018 was a year that reset the benchmarks – new management team, ...

Read Article »

Redx Pharma Strategy launch

Hardman & Co

Redx Pharma (LON:REDX) new management team is continuing to focus its financial resources on progressing lead candidates in oncology and fibrotic disease into the clinic. An extensive internal review, led ...

Read Article »

Redx Pharma Back to the clinic

Hardman & Co

Redx Pharma Plc (LON:REDX) new management team is continuing to focus its financial resources on progressing its lead candidates in oncology and fibrotic disease into the clinic. When the first ...

Read Article »

Redx Pharma Streamlined and clean

Hardman & Co

Redx Pharma Plc (LON:REDX) has emerged from administration with a refocused R&D pipeline and in a very clean financial state with £13.6m net cash in the bank. The group’s strategy ...

Read Article »